Skip to main content
FinSpry Logo
FinSpry
MYGN logo
MYGN
(NASDAQ)
Myriad Genetics, Inc.
$4.75-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Myriad Genetics (MYGN) Stock Price & Financial Analysis

Myriad Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.44 - $4.83
52-Week High$8.97
52-Week Low$3.76
Open$4.45
Volume1.15M
Average Volume (3M)1.15M
Market Cap443.18M
Shares Outstanding93.30M
Price to Sales (P/S)0.52
Price to Book (P/B)1.16
EV/EBITDA-1.22
Revenue (TTM)824.50M
Net Income (TTM)-365.90M
Free Cash Flow (TTM)-19.60M
EPS (TTM)$-3.92
Profit Margin-44.38%
Operating Margin6.69%
Return on Equity (ROE)-99.43%
Debt to Equity0.57
50-Day MA$4.95
200-Day MA$6.09
52-Week Change-48.08%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateJul 1, 2009

Frequently Asked Questions About Myriad Genetics

What is the current stock price for MYGN?

As of the latest trading session, MYGN stock trades at $4.75. The 52-week range is $3.76–$8.97, with a day range of $4.44–$4.83.

What is the P/E ratio for MYGN?

The P/E ratio (Price-to-Earnings) for MYGN is shown in the Key Statistics section. This valuation metric helps compare Myriad Genetics, Inc. to industry peers.

Does MYGN pay dividends?

Myriad Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MYGN?

Based on 2 analysts, the consensus for MYGN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MYGN?

Myriad Genetics's market capitalization is $443.2M, classifying it as a small-cap company. Myriad Genetics operates in the Healthcare sector within the Diagnostics & Research industry.